Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class

Details Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class

1994-04-05

1998-03-03

Cunningham, Thomas M.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

4241841, 435 693, 530300, 530324, 530395, 530868, 514 2, 514 12, A61K 3800, C07K 1474

Patent

active

057231281

ABSTRACT:
Fragments from the polymorphic domains of Class I HLA antigen domains are used to modulate T-cell activity. The peptides are from the .alpha.1- or .alpha.2 domains, particularly of the HLA-A, and B antigens. The peptides may be conjugated to other compounds to be used in diagnosis and therapy. The peptides may block lysis, CTL proliferation or have other regulating effects.

REFERENCES:
patent: 4634590 (1987-01-01), Cohen et al.
patent: 4681760 (1987-07-01), Fathman
patent: 5073540 (1991-12-01), Olsson
patent: 5451512 (1995-09-01), Apple et al.
Auffray et al., J. Human Immunology (1986) 15:381-390.
Biddison et al., J. Immunol., (1980) 124(2):548-552.
Clayberger et al., J. Exp. Med. (1985) 163:1709-1714.
Cowan et al., J. Immunol. (1985) 135:2835-2841.
Duran et al., Transplantation, (1986) 41(3):279-285.
Gaston et al., J. Exp. Med. (1983) 158:280-293.
Holmes et al., EMBO Journal, (1985) 4:2849-2854.
Koller et al., J. Imunol. (1985) 134:2727-2733.
Krangel et al., Biochemistry (1982) 21:6313-6321.
Krangel et al., J. Immunol. (1983) 130:1856-1862.
Krangel et al., J. Exp. Med. (1983) 157:324-336.
Nathenson et al., Ann. Rev. Immunol. (1986) 4:471-502.
Parham et al., Chemical Abstracts (1987) 106:516, abstract No. 154384 x.
Pease et al., Proc. Natl. Acad. Sci. (1983) 80:242-246.
Pierschbacher et al., Nature (1984) 309:30-33.
Salter et al., J. Exp. Med. (1987) 166:283-288.
Schulz et al., Proc. Natl. Acad. Sci. (1983) 80:2007-2011.
Spits et al., Immunogenetics, (1982) 16:503-512.
Taketani et al., J. Immunol. (1984) 133:816-821.
Towsend et al., (1986) Cell, (1986) 44:959-968.
Vega et al., Proc. Natl. Acad. Sci. (1985) 82:7394-7398.
Ways et al., J. Biol. Chem. (1985) 26:11924-11933.
Yamada et al., J. Cell. Biol. (1985) 28:99-104.
S. Nisco et al., Journal of Immunology, vol. 152, No. 8, pp. 3786-3792 (1994).
M.C. Cuturi et al., Transplantation, vol. 59, No. 9, pp. 661-669 (1995).
Clayberger et al., "Determinants Recognized by Human Cytotoxic T Cells on a Natural Hybrid Class 1 LA Molecule", J. Exp. Med., 11:1709-1714 (1985).
Cowan et al. "Molecular Cloning and DNA Sequence Analysis of Genes Encoding Cytotxic T Lymphocyte-defined HLA-A3 Subtypes: The E1 Subtype", J. of Immunology, 135(4):2835-2840 (1985).
Gaston et al., "Epstein-Barr Virus-specific Cytotoxic T Lymphocytes as Probes of HLA Polymoorphism", J. Exp. Med., 158:280-293 (1983).
Holmes and Parham, "Exon Shuffling in vivo can Generate Novel HLA Class I Molecules", Eur. Mol. Biol. Organ J., 4(11):2849-2854 (1985).
Nisco et al., "Induction of Allograft Tolerance in Rats by an HLA Class-I-Derived Peptide and Cyclosporine A.sup.1 ", J. of Immunology, 152:3786-3792 (1994).
Pierschbacher and Ruoslahti, "Cell Attachment Activity of Fibronectin can be Duplicated by Small Synthetic Fragments of the Molecule", Nature, 309:30-33 (1984).
Salter et al., "In vitro Mutagenesis at a Single Residue Introduces B and T Cell Epitopes into a Class I HLA Molecule", J. Exp. Med., 166:283-288 (1987).
Townsend et al., "The Epitopes of Influenza Nucleoprotein Recognized by Cytotoxic T Lymphocytes can be Defined with Short Synthetic Peptides", Cell, 44:959-968 (1986).
Vega et al., "Structural Analysis of an HLA-B27 Functional Variant: Identification of Residues that Contribute to the Specificity of Recognition by Cytolytic T Lymphocytes", Proc. Natl. Acad. Sci. USA, 82:7394-7398 (1985).
Chen, et al., "Cytotoxic T Cell Recognition of an Endogenous Class I HLA Peptide Presented by a Class II HLA Molecule," J. Exp. Med. (1990) 172:779-788.
Rojo, et al., "HLA-B27 Antigenicity: Antibodies Against the Chemically Synthesized 63-84 Peptide from HLA-B27.1 Display Alloantigenic Specificity and Discriminate Among HLA-B27 Subtypes," J. Immunol. (1986) 137:904-910.
Raybourne, et al., "Monoclonal Antibodies Against an HLA-B27-Derived Peptide React with an Epitope Present on Bacterial Proteins," J. Immunol. (1990) 145:2539-2544.
Heath, et al., "Mapping of Epitopes Recognized by Allorective Cytotoxic T Lymphocytes Usig Inhibition by MHC Peptides," J. Immunol. (1989) 143:1441-1446.

Affiliated with

Also associated with

Rating

Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2245590